…d the treatment of hematologic malignancies, its application to epithelial cancers remains limited by unpredictable toxicities. Insights from CD19…
hematologic malignancies
This disease is selected. Its supporting articles are shown below.
Articles mentioning hematologic malignancies
34 articles · page 3 of 3… receptor (CAR) T cell therapy has revolutionized treatment for hematologic malignancies, but response rates vary significantly among patients, even whe…
…ad to superior clinical outcomes for IB-T101 CAR-T cells in the ccRCC solid tumor setting.Methods Here we report an in-progress phase…
…y targeting epidermal growth factor receptor (EGFR) in advanced solid tumors with human leukocyte antigen (HLA) loss of heterozygosity (LOH)…
…c murine models of extensive metastatic lung adenocarcinoma and melanoma to evaluate CAR T cell therapy following tumor irradiation. CAR…
…ies have shown success in hematologic malignancies, efficacy in solid tumors has been limited, partly due to T-cell exhaustion within the im…
…systems we currently employ. To address this issue we generated Acute Myeloid Leukemia (AML) and Ovarian Cancer (OC) models using three different mous…
…erged as an advanced and highly effective approach for treating hematologic malignancies with its scope rapidly expanding to encompass diverse applicati…
…l with metabolic enhancement to improve therapeutic efficacy in solid tumors.Methods To overcome these barriers, we developed a next-generat…
…ibitors and T cell therapies have mediated durable responses in hematologic malignancies and select solid tumors, most patients still relapse or fail to…